Westfield Capital Management
NTGN

Westfield Capital Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Westfield Capital Management’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-31,400
Closed -$149K – 265
2019
Q2 		$149K Buy
+31,400
New +$176K ﹤0.01% 243

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westfield Capital Management's NTGN Position: Q3 2019 in Review

Westfield Capital Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 31,400 shares — an estimated $149K sold.

Westfield Capital Management first reported a position in NTGN in Q2 2019 and held it in 1 quarter. The position peaked at $149K in Q2 2019. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • Westfield Capital Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Westfield Capital Management sold 31,400 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $149K.
  • Westfield Capital Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Westfield Capital Management's Neon Therapeutics, Inc. Common Stock position peaked at $149K in Q2 2019.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Westfield Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.